I hope that you will find where I go
with the decision making under uncertainty thread to be interesting (no I am going nowhere near what the policies should actually look like).
Not exact matches
These risks and
uncertainties include, among others: the unfavorable outcome of litigation, including so - called «Paragraph IV» litigation and other patent litigation, related to any of our products or products using our proprietary technologies, which may lead to competition from generic drug manufacturers; data from clinical trials may be interpreted by the FDA in different ways than we interpret it; the FDA may not agree
with our regulatory approval strategies or components of our filings for our products, including our clinical trial designs, conduct and methodologies and, for ALKS 5461, evidence of efficacy and adequacy of bridging to buprenorphine; clinical development activities may not be completed on time or at all; the results of our clinical development activities may not be positive, or predictive of real - world results or of results in subsequent clinical trials; regulatory submissions may not occur or be submitted in a timely manner; the company and its licensees may not be able to continue to successfully commercialize their products; there may be a reduction in payment rate or reimbursement for the company's products or an increase in the company's financial obligations to governmental payers; the FDA or regulatory authorities outside the U.S. may
make adverse
decisions regarding the company's products; the company's products may prove difficult to manufacture, be precluded from commercialization by the proprietary rights of third parties, or have unintended side effects, adverse reactions or incidents of misuse; and those risks and
uncertainties described
under the heading «Risk Factors» in the company's most recent Annual Report on Form 10 - K and in subsequent filings
made by the company
with the U.S. Securities and Exchange Commission («SEC»), which are available on the SEC's website at www.sec.gov.
Economists and systems analysts have devoted considerable attention to «
decision -
making under conditions of
uncertainty,» and fairly sophisticated ethical machinery has been developed for dealing
with these macroethical problems.
The type of
decisions that serious poker players have to
make under conditions of stress and
uncertainty bear a number of similarities to those that investors are faced
with.
But what I would like to do in the forthcoming series on
decision making under climate
uncertainty is to explore how we might approach reframing the strategy for identifying robust policy options for dealing
with climate change in the context of the broader challenges to sustainability.
This paragraph...: «But what I would like to do in the forthcoming series on
decision making under climate
uncertainty is to explore how we might approach reframing the strategy for identifying robust policy options for dealing
with climate change in the context of the broader challenges to sustainability.»
This technical document contributes to frame the challenge of dealing
with extreme weather and climate events as an issue in
decision -
making under uncertainty, analyzing response in the context of risk management.
This document contributes to frame the challenge of dealing
with extreme weather and climate events as an issue in
decision -
making under uncertainty, analyzing response in the context of risk management.
The Bristol meeting brings together scientists and practitioners
with the goal of (a) developing more effective means to communicate
uncertainty and (b) to explore how
decision making under uncertainty can be better informed by scientific constraints.
We don't need to come up
with such a new buzzphrase (though it's always a good way to
make a name for oneself —
with all due respect, but I think that might be one of the motives of its proponents)-- we don't need this PNS to
make bring up the level of
uncertainty under which life - critical
decisions have to be
made, in the fog of war, or in the operating room.
Assuming that climate change and other deep
uncertainties can not be eliminated over the short term (and probably even over the longer term), it then summarizes existing
decision -
making methodologies that are able to deal
with climate - related
uncertainty, namely cost - benefit analysis
under uncertainty, cost - benefit analysis
with real options, robust
decision making, and climate informed
decision analysis.
This analysis is based on a set of interviews
with decision - makers, in particular World Bank project leaders, and on a literature review on
decision -
making under uncertainty.
Lee breaks new ground (as far as I know, anyways) regarding the ethics of
decision making under deep
uncertainty,
with some profound conclusions regarding mitigation versus adaptation:
Lee breaks new ground (as far as I know, anyways) regarding the ethics of
decision making under deep
uncertainty,
with some profound conclusions regarding mitigation versus adaptation: «I assume here that the greater the speculation and
uncertainties involved, the weaker the ethical claim.
This notwithstanding, I wholeheartedly agree
with Gavin that these kinds of probabilistic projections aren't appropriate for risk analysis and
decision making under uncertainty and won't be for a long time.